October is Attention-Deficit/Hyperactivity Disorder (ADHD) Awareness Month
Neuroscience Education Institute
Your top mental health resource for point-of-care tools and continuing education
October is ADHD Awareness Month. Our goal this month to provide access to accurate, practical, and insightful education and resources related to optimizing the diagnosis and treatment of ADHD. ADHD continues through adolescence and into adulthood, affecting approximately 5% of the child population worldwide and 2% to 4% of the adult population worldwide. Comorbid conditions are common and obscure ADHD diagnosis and make it difficult for patients to receive optimal treatment. With an emphasis on educational materials that inspire learning, NEI strives to create activities and resources that simplify complex scientific concepts related and create an enhanced learning experience that is engaging, entertaining, and rapidly promotes understanding and enhances retention.
Ready to Start Learning?
New to NEI? Create your free account in less than 60 seconds
NEI Member-Only Activities and Practice Tools
NEI's Patient Education resources are designed to foster collaboration and communication, empowering patients to take an active role in their treatment journey. View the Member library of Patient Education resources specifically for patients with on ADHD.
Want even more online CME/CE? Join NEI as a Member to gain access to all our full library of online education and practice tools, such as the activities listed below:
What Non-Stimulant Medications Are Used for Treating ADHD?
What are the FDA-approved nonstimulant medications for adult with ADHD? What agents are used off-label? How do nonstimulants work? When are nonstimulants prescribed in patients diagnosed with ADHD? In this clip, Dr. David Goodman addresses questions regarding nonstimulants used for treating ADHD.
Originally presented by Dr. David Goodman at the 2023 NEI Congress session titled "The Other Meds: Nonstimulant Treatment Options for ADHD".
Recommended by LinkedIn
ADHD and Comorbidities: What Should Be Treated First?
In a patient with attention-deficit/hyperactivity disorder (ADHD) and comorbid disorders, it is imperative to treat all disorders appropriately, and in terms of highest degree of impairment. This might mean that in one patient it is necessary to first stabilize the alcohol abuse, while in another patient the symptoms of ADHD might be more impairing than the underlying anxiety disorder. Additionally, some medications used to treat these disorders could exacerbate the comorbid ailment. Thus, care needs to be taken when choosing the appropriate treatment. An individualized treatment plan should be established for each patient based on his/her symptomatic portfolio. In this clip, Dr. Stephen Stahl reviews how to treat patients with attention-deficit/hyperactivity disorder (ADHD) and comorbid disorders.
This clip from the NEI Stahl’s Essential Videos– Chapter 11b: Treatment of ADHD.
What Does the Research Say About Over-the-Counter Supplements Used for Treating ADHD Symptoms?
Nutraceuticals (such as Prevegen and Neuriva) are heavily marketed over-the-counter supplements for ADHD. But do they work? In this clip, Dr. David Goodman discusses the efficacy of nutraceuticals for treating ADHD and reminds us to inform our patients about what the research show.
Originally presented by Dr. David Goodman at the 2022 NEI Synapse, session titled, "Throughout the Lifespan: Optimizing Treatment for ADHD".
Is Breastfeeding Contraindicated in Patients Who are on ADHD Medication?
There is a lack of data regarding the risks of stimulant and non-stimulant medication with lactation (only case reports; low-quality evidence), and long-term consequences have not been studied. While some women may be able to discontinue ADHD medications during pregnancy and/or lactation without adverse effects, others may experience significant functional impairment which may lead to a loss of productivity at work or school and associated financial stressors, an exacerbation of comorbid psychiatric conditions, and psychosocial stressors affecting interpersonal relationships. The maternal cost associated with stopping stimulant treatment remains unknown. Due to the rising number of ADHD medication prescribed to women at childbearing age, it is important to determine which medications can be considered relatively safe in pregnancy and lactation. In this clip, Dr. David Goodman discusses treating ADHD during breastfeeding.
Originally presented by Dr. David Goodman at the 2022 NEI Synapse, session titled, "ADHD, Female Hormones, and Menopause: The Little We Know From the Research"
What is the Link Between ADHD and Anxiety?
Attention-deficit/hyperactivity disorder (ADHD) and anxiety disorders are highly comorbid conditions. Understanding the relationship between these conditions is crucial for managing symptoms and improving overall well-being. Dr. Jeffrey Strawn explains in the video below.
Originally presented by Dr. Jeffrey Strawn at the 2023 NEI Congress Child & Adolescent Psychiatry Academy, session titled, "Along for the Ride: Treatment Considerations for Childhood Psychiatric Disorders With Co-Occurring Anxiety".